Mapmygenome completes acquisition of dnaPower Inc

SENSEX 73,709.69

 -143.21

NIFTY 22,811.35

 -77.60

CRUDEOIL 9,188.00

 -123.00

GOLD 146,142.00

 -377.00

SILVER 209,506.00

 -1,979.00

SENSEX 73,709.69

 -143.21

NIFTY 22,811.35

 -77.60

NIFTY 22,811.35

 -77.60

CRUDEOIL 9,188.00

 -123.00

CRUDEOIL 9,188.00

 -123.00

GOLD 146,142.00

 -377.00

'; } document.getElementById("lgdv").innerHTML = htmlElements; } function numberformat(i) { return Number(parseFloat(i).toFixed(2)).toLocaleString('en', { minimumFractionDigits: 2 }) } async function gatherResponse(response) { const { headers } = response; const contentType = headers.get('content-type') || ''; if (contentType.includes('application/json')) { return await response.json() } return response.text(); } function getWidth() { if (Math.max(document.body.scrollWidth,document.documentElement.scrollWidth,document.body.offsetWidth,document.documentElement.offsetWidth,document.documentElement.clientWidth) > 991) { document.getElementById("mob").style.display = "none"; document.getElementById("lgdv").style.display = "block"; } else { document.getElementById("mob").style.display = "block"; document.getElementById("lgdv").style.display = "none"; } } getWidth(); THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.

Mapmygenome CEO Anu Acharya says the acquisition creates a central platform for DNA, microbiome, pharmacogenetic, and longevity testing in North America

By BL Hyderabad Bureau

Updated - October 21, 2026 at 09:28 PM. | Hyderabad

Mapmygenome, a Hyderabad-based personal genomics solutions company, has completed the acquisition of Vancouver-based dnaPower Inc., which also operates in the same space.

“The transaction expands Mapmygenome’s North American footprint and establishes a market-leading platform in DNA testing, gut microbiome health, longevity, and AI-driven multi-omics testing,” a statement said.

The company, however, has not divulged the size of the deal.

Mapmygenome Founder-CEO Anu Acharya said that by uniting dnaPower with Mapmygenome’s global presence, the acquisition creates a centralised platform for DNA, microbiome, pharmacogenetic, and longevity testing services in North America.

Published on October 21, 2026

THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.Sign into Unlock benefits!

• Access 10 free stories per month
• Get notified by email for early preview to new features, discounts & offers